Drugmakers are scrambling to find a suitable response to the debate on pharmaceutical pricing. During the recent Prix Galien Forum in New York City, Merck CEO Kenneth Frazier, discussed Turing Pharmaceuticals, and the current pharmaceutical pricing debate. See the responses by Merck, Pfizer, Biogen, Eli Lilly, Roche and more here. (Source: Jaimy Lee, MM&M, 11/12/15)
You are here: / / How Are Drugmakers Responding to the Pricing Debate?